CRISPR/Cas-Based Modifications for Therapeutic Applications: A Review
- 6 November 2021
- journal article
- review article
- Published by Springer Nature in Molecular Biotechnology
- Vol. 64 (4) , 355-372
Abstract
The CRISPR–Cas genome editing system is an intrinsic property of a bacteria-based immune system. This employs a guide RNA to detect and cleave the PAM-associated target DNA or RNA in subsequent infections, by the invasion of a similar bacteriophage. The discovery of Cas systems has paved the way to overcome the limitations of existing genome editing tools. In this review, we focus on Cas proteins that are available for gene modifications among which Cas9, Cas12a, and Cas13 have been widely used in the areas of medicine, research, and diagnostics. Since CRISPR has been already proven for its potential research applications, the next milestone for CRISPR will be proving its efficacy and safety. In this connection, we systematically review recent advances in exploring multiple variants of Cas proteins and their modifications for therapeutic applications.Keywords
This publication has 121 references indexed in Scilit:
- Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirusScientific Reports, 2013
- Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidisProceedings of the National Academy of Sciences, 2013
- One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome EngineeringCell, 2013
- The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systemsRNA Biology, 2013
- Efficient genome editing in zebrafish using a CRISPR-Cas systemNature Biotechnology, 2013
- CRISPR RNA maturation by trans-encoded small RNA and host factor RNase IIINature, 2011
- Short Hairpin RNA (shRNA): Design, Delivery, and Assessment of Gene Knockdown2010
- Small CRISPR RNAs Guide Antiviral Defense in ProkaryotesScience, 2008
- Chimeric Nucleases Stimulate Gene Targeting in Human CellsScience, 2003
- Long stretches of short tandem repeats are present in the largest replicons of the Archaea Haloferax mediterranei and Haloferax volcanii and could be involved in replicon partitioningMolecular Microbiology, 1995